Information Provided By: 
Fly News Breaks for March 3, 2016
LHCG
Mar 3, 2016 | 06:48 EDT
Piper Jaffray analyst Kevin Ellich believes shares of LHC Group could trade lower on the company's "disappointing" 2016 guidance. Guidance would have been higher than Street estimates excluding reimbursement changes, and there could be upside to the outlook due to acquisitions and changes in home health patient mix, Ellich tells investors in a post-earnings research note. He recommends buying the stock today on any weakness and keeps an Overweight rating on LHC with a $45 price target.
News For LHCG From the Last 2 Days
There are no results for your query LHCG
